The study reveals that AI systems offer promising accuracy in predicting treatment outcomes, particularly when used to ...

There is minimal spatial or temporal heterogeneity in ovarian cancer biomarkers, making initial testing generally reliable throughout treatment. The NCCN recommends universal FRα testing as part ...

Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women ...

Multiple omics researches in the past two decades have identified over 200 potential biomarkers for ovarian cancer. Discoveries during the 1990s were more focused on clinicopathology-based ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

A common test for ovarian cancer may be less effective on Black and Native American patients, new research has found. One of the two most common ways to test for ovarian cancer is to check for ...

1 Experimental Therapeutics, British Columbia Cancer ... Canada Epithelial ovarian cancers consist of multiple tumor types that are currently treated the same despite their heterogeneity in ...

If you have ovarian cancer, your outcomes will be better if you are treated by a gynecologic oncologist right from the beginning. Fred Hutch Cancer Center has more gynecologic oncologists than any ...